AKT1 and prostate cancer: Overall, these findings indicate that androgen signaling has complex crosstalk with Wnt/β-catenin and PI3K/Akt signaling, and may enable prostate cancer cell stemness through Wnt/β-catenin and PI3K/Akt signaling.